CatalystFDA/Bio

Artelo Biosciences Enrolls First Patient In Phase 2 Glaucoma Study Of ART27.13

First-patient enrollment in Phase 2 glaucoma trial advances ART27.13 clinical pipeline.

What changed

Why it matters

First-patient enrollment in Phase 2 glaucoma trial advances ART27.13 clinical pipeline.

Sources